跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,807 条关于
“anti-CD19/CD20 CAR”
全部
46,807
临床试验
32,584
药物
5,560
机构
437
资讯
8,226
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
去年
Kite Highlights CAR T-cell Therapy Portfolio with Positive Survival Outcomes at ASH 2024
去年
Johnson & Johnson's Dual-Targeting CAR-T Therapy Achieves 80% Complete Response Rate in Lymphoma Trial
10个月前
Legend Biotech to Present Comprehensive CARVYKTI Data and First-in-Human Allogeneic CAR-T Results at ASH 2025
去年
Dual-Targeted CAR T-Cell Therapy Shows 100% Response Rate in Relapsed/Refractory Mantle Cell Lymphoma
去年
Zamto-cel Shows Promise in Relapsed/Refractory DLBCL with Tandem CD20/CD19 Targeting
3年前
Bispecific CD20/CD19 CAR T-Cell Therapy Shows Promising Results in Mantle Cell Lymphoma
去年
CARsgen's THANK-u Plus Platform Drives Advancements in Allogeneic CAR-T Therapy for Hematologic Malignancies
去年
ImmunityBio's CD19 CAR-NK Therapy Achieves Complete Responses in Late-Stage Waldenstrom Macroglobulinemia
去年
Shark-Derived VNARs Show Promise in Targeting CD20 for Lymphoma Therapy
第 1 页,共 823 页
上一页
下一页